Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
British Journal of Haematology
|
January 14, 1999
Dyskeratosis Congenita (DC) Registry: identification of new features of DC
S Knight, T Vulliamy, A Copplestone, et al.
Bone Marrow Transplantation
|
August 29, 2007
Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan
K Amarasinghe, C Dalley, I Dokal, et al.
British Journal of Haematology
|
February 13, 2001
Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation
M McCloy, A Almeida, P Daly, et al.
Clinical and Experimental Dermatology
|
March 19, 2014
X-linked dyskeratosis congenita presenting in adulthood with photodamaged skin and epiphora
J B Powell, I Dokal, R Carr, et al.
Clinical Genetics
|
January 5, 2011
Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2
T Vulliamy, R Beswick, M J Kirwan, et al.
British Journal of Haematology
|
October 23, 1997
Successful second bone marrow transplant for Fanconi's anaemia following escalation of conditioning
J O'Donnell, I Roberts, J De la Fuente, et al.
Leukemia
|
August 21, 2010
Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation
B G Jaganathan, V Tisato, T Vulliamy, et al.
Journal of Medical Genetics
|
December 1, 1996
Fine mapping of the dyskeratosis congenita locus in Xq28
S W Knight, T Vulliamy, G L Forni, et al.
Nature
|
September 28, 2001
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
T Vulliamy, A Marrone, F Goldman, et al.
Human Genetics
|
May 31, 2001
Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis
S W Knight, T J Vulliamy, B Morgan, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
British Journal of Haematology
|
January 14, 1999
Dyskeratosis Congenita (DC) Registry: identification of new features of DC
S Knight, T Vulliamy, A Copplestone, et al.
Bone Marrow Transplantation
|
August 29, 2007
Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan
K Amarasinghe, C Dalley, I Dokal, et al.
British Journal of Haematology
|
February 13, 2001
Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation
M McCloy, A Almeida, P Daly, et al.
Clinical and Experimental Dermatology
|
March 19, 2014
X-linked dyskeratosis congenita presenting in adulthood with photodamaged skin and epiphora
J B Powell, I Dokal, R Carr, et al.
Clinical Genetics
|
January 5, 2011
Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2
T Vulliamy, R Beswick, M J Kirwan, et al.
British Journal of Haematology
|
October 23, 1997
Successful second bone marrow transplant for Fanconi's anaemia following escalation of conditioning
J O'Donnell, I Roberts, J De la Fuente, et al.
Leukemia
|
August 21, 2010
Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation
B G Jaganathan, V Tisato, T Vulliamy, et al.
Journal of Medical Genetics
|
December 1, 1996
Fine mapping of the dyskeratosis congenita locus in Xq28
S W Knight, T Vulliamy, G L Forni, et al.
Nature
|
September 28, 2001
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
T Vulliamy, A Marrone, F Goldman, et al.
Human Genetics
|
May 31, 2001
Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis
S W Knight, T J Vulliamy, B Morgan, et al.
Page
of 6